Atomwise helps emerging biotechnology companies accelerate their innovations with AI-based drug discovery.
Emerging biotechnology companies don't always have access to the most cutting edge tools for AI and machine learning. Partnership with Atomwise gives them this access so they can transform their discoveries into drug programs.
The synergy of the biology exploration by our partners and chemical exploration with our AtomNet® technology creates discoveries that neither partner could have achieved alone. Together we form joint ventures to advance therapies for disease areas with unmet needs.
Our JV support offers added value by providing resources, expertise, and professional services throughout the entrepreneurship journey.
Our ecosystem includes partners for chemical synthesis, assay development, and pre-clinical studies, helping our partners advance through drug discovery process.
Atomwise can create connections that drive value and investment through marketing resources, incubators and accelerator programs, seed and venture capital.
Contact us to learn more about our partnering opportunities.